Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Nuermberger

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Microbiology Spectrum|June 24, 2017
Preclinical Efficacy Testing of New Drug CandidatesEric L Nuermberger
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Significance of macrolide resistance in Streptococcus pneumoniaeEric L Nuermberger, William R Bishai
The New England Journal of Medicine|June 8, 2012
Confronting multidrug-resistant tuberculosisRichard E Chaisson, Eric L Nuermberger
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?Eric L Nuermberger, William R Bishai
Nature Medicine|March 8, 2024
Restocking the tuberculosis drug arsenalEric L Nuermberger, Richard E Chaisson
Plos One|January 19, 2012
Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacyTianyu Zhang, Si-Yang Li, Eric L Nuermberger
Drug Discovery Today|July 5, 2014
Minding the gaps in tuberculosis researchSean Ekins, Eric L Nuermberger, Joel S Freundlich
Disease Models & Mechanisms|June 3, 2015
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosisJean-Philippe Lanoix, Anne J Lenaerts, Eric L Nuermberger
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2015
Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Jean-Philippe Lanoix, Richard E Chaisson, Eric L Nuermberger
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Drug Efficacy Testing in the Mouse Footpad Model of Buruli UlcerPaul J Converse, Deepak V Almeida, Eric L Nuermberger
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Microbiology Spectrum|June 24, 2017
Preclinical Efficacy Testing of New Drug CandidatesEric L Nuermberger
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Significance of macrolide resistance in Streptococcus pneumoniaeEric L Nuermberger, William R Bishai
The New England Journal of Medicine|June 8, 2012
Confronting multidrug-resistant tuberculosisRichard E Chaisson, Eric L Nuermberger
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2004
Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?Eric L Nuermberger, William R Bishai
Nature Medicine|March 8, 2024
Restocking the tuberculosis drug arsenalEric L Nuermberger, Richard E Chaisson
Plos One|January 19, 2012
Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacyTianyu Zhang, Si-Yang Li, Eric L Nuermberger
Drug Discovery Today|July 5, 2014
Minding the gaps in tuberculosis researchSean Ekins, Eric L Nuermberger, Joel S Freundlich
Disease Models & Mechanisms|June 3, 2015
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosisJean-Philippe Lanoix, Anne J Lenaerts, Eric L Nuermberger
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2015
Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Jean-Philippe Lanoix, Richard E Chaisson, Eric L Nuermberger
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2021
Drug Efficacy Testing in the Mouse Footpad Model of Buruli UlcerPaul J Converse, Deepak V Almeida, Eric L Nuermberger
Pageof 14